Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Lalario

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Heart Failure Clinics|June 6, 2024
Clinical Use of Biomarkers in Cardiac AmyloidosisAndrea Lalario, Riccardo Saro, Gianfranco Sinagra, et al.
Giornale Italiano Di Cardiologia (2006)|March 25, 2025
[Cerebral amyloid angiopathy and left atrial appendage occlusion: evidence and possible management for a collaborative approach between Cardiology and Neurology]Andrea Lalario, Enrico Fabris, Serena Rakar, et al.
Journal of Cardiovascular Development and Disease|February 24, 2023
Sudden Cardiac Death in Athletes: Facts and FallaciesJennie Han, Andrea Lalario, Enzo Merro, et al.
Medicina Clinica|September 8, 2023
Impact of SARS-CoV-2 infection in patients with cardiac amyloidosis: Results of a multicentre registryJosé M Larrañaga-Moreira, Ana I Rodriguez-Serrano, Fernando Domínguez, et al.
JACC. Case Reports|August 22, 2025
Fulminant Myocarditis Presenting With Refractory Ventricular Fibrillation During BRAF/MEK Inhibitor TherapyAndrea Lalario, Filippo Maria Rubbo, Giulia Bassetto, et al.
Heart Failure Clinics|June 6, 2024
Tafamidis in the Treatment of ATTR-related Cardiomyopathy: Indications and Grey ZonesTeresa Maria Capovilla, Andrea Lalario, Maddalena Rossi, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|June 13, 2024
Abnormal conduction-induced cardiomyopathy: a poorly explored entityAndrea Lalario, Maddalena Rossi, Valentina Allegro, et al.
Biomedicines|July 27, 2022
Re-Definition of the Epidemiology of Cardiac AmyloidosisMaddalena Rossi, Guerino Giuseppe Varrà, Aldostefano Porcari, et al.
ESC Heart Failure|June 23, 2022
Clinical characterization and natural history of chemotherapy-induced dilated cardiomyopathyAndrea Lalario, Eva Del Mestre, Michele Lo Casto, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|April 24, 2023
Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathyEva Del Mestre, Carola Pio Loco Detto Gava, Alessia Paldino, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Heart Failure Clinics|June 6, 2024
Clinical Use of Biomarkers in Cardiac AmyloidosisAndrea Lalario, Riccardo Saro, Gianfranco Sinagra, et al.
Giornale Italiano Di Cardiologia (2006)|March 25, 2025
[Cerebral amyloid angiopathy and left atrial appendage occlusion: evidence and possible management for a collaborative approach between Cardiology and Neurology]Andrea Lalario, Enrico Fabris, Serena Rakar, et al.
Journal of Cardiovascular Development and Disease|February 24, 2023
Sudden Cardiac Death in Athletes: Facts and FallaciesJennie Han, Andrea Lalario, Enzo Merro, et al.
Medicina Clinica|September 8, 2023
Impact of SARS-CoV-2 infection in patients with cardiac amyloidosis: Results of a multicentre registryJosé M Larrañaga-Moreira, Ana I Rodriguez-Serrano, Fernando Domínguez, et al.
JACC. Case Reports|August 22, 2025
Fulminant Myocarditis Presenting With Refractory Ventricular Fibrillation During BRAF/MEK Inhibitor TherapyAndrea Lalario, Filippo Maria Rubbo, Giulia Bassetto, et al.
Heart Failure Clinics|June 6, 2024
Tafamidis in the Treatment of ATTR-related Cardiomyopathy: Indications and Grey ZonesTeresa Maria Capovilla, Andrea Lalario, Maddalena Rossi, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|June 13, 2024
Abnormal conduction-induced cardiomyopathy: a poorly explored entityAndrea Lalario, Maddalena Rossi, Valentina Allegro, et al.
Biomedicines|July 27, 2022
Re-Definition of the Epidemiology of Cardiac AmyloidosisMaddalena Rossi, Guerino Giuseppe Varrà, Aldostefano Porcari, et al.
ESC Heart Failure|June 23, 2022
Clinical characterization and natural history of chemotherapy-induced dilated cardiomyopathyAndrea Lalario, Eva Del Mestre, Michele Lo Casto, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|April 24, 2023
Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathyEva Del Mestre, Carola Pio Loco Detto Gava, Alessia Paldino, et al.
Pageof 2